Fairfax Financial to invest further $500mn in Seaspan

By zaymalz malz
Share

It has been revealed that leading Canadian financial holdings company Fairfax Financial has agreed to invest a further $500mn in Seaspan Corporation, the world’s largest independent containership owner and operator.

The investment, coming in the form of two tranches, will raise Fairfax’s total investment to $1bn. The company will purchase 38.46mn Class A shares at $6.50 per share on 16 July, later investing $250mn in January 2019.

See also:

“With foundational, long-term oriented partners like Fairfax and the Washington family, we have the opportunity to build on our industry-leading position to drive growth and sustainable shareholder value creation for many years to come,” said David Sokol, Chairman of Seaspan Corporation.

Hong Kong-based Seaspan currently operates 112 constainerships with a total capacity of 900,000 twenty-foot equivalent (TEU).

“We are excited about Seaspan's outstanding progress over the past six months, and with David Sokol's proven capital allocation and shareholder value creation credentials, we are thrilled to expand our relationship,” Said Fairfax Chairman and Chief Executive Officer, Prem Watsa.

The closing of the transaction is subject to regulatory approval and customary closing conditions.

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy